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Differential predictive value of depressive versus anxiety symptoms in the 
prediction of 8-year mortality following acute coronary syndrome 
Abstract 
Objective: Both depression and anxiety and been associated with poor prognosis in 
patients with acute coronary syndrome (ACS). However, certain symptoms, and how 
they are measured, may be more important than others. We investigated 3 different 
scales to determine their predictive validity in a national sample. 
Methods: Patients with ACS (N=598) completed either the Hospital Anxiety and 
Depression Scales (HADS-A, HADS-D; N=316) or the Beck Depression Inventory-Fast 
Screen (BDI-FS; N=282). Their all-cause mortality status was assessed at 8 years.  
Results: During follow-up 20% (121/598) of participants died. Cox proportional 
hazards modelling showed that the HADS-D was predictive of mortality (Hazard Ratio 
[HR]=1.11, 95% CI 1.04–1.19), and this association remained significant after 
adjustment for major clinical/demographic factors. The HADS-A (HR=0.96, 95% CI 
0.85–1.09), and the BDI-FS (HR=0.99, 95% CI 0.91–1.08) were not. The following 
depression items from the HADS-D predicted mortality: "I still enjoy the things I 
used to enjoy" (HR=1.38, 95% CI 1.05-1.82), "I can laugh and see the funny side of 
things" (HR=1.48, 95% CI 1.11-1.96), "I feel as if I am slowed down" (HR=1.66, 95% 
CI 1.24-2.22) and "I look forward with enjoyment to things" (HR=1.36, 95% CI 1.08-
1.72). 
Conclusions: Depressive symptoms related to lack of enjoyment or pleasure and 
physical or cognitive slowing, as measured by the HADS-D, predicted all-cause 
mortality over 8 years in patients with ACS. Other depressive and anxiety symptoms did 
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not. Whether symptoms of distress predict prognosis in ACS seems to be dependent on 
the measures and items used. 
Keywords: Depression; mortality; coronary heart disease; prognosis; anhedonia; anxiety 
 
Acronyms 
ACS = acute coronary syndrome 
BDI-FS = Beck Depression Inventory – Fast Screen 
CI = confidence interval 
HADS = Hospital Anxiety and Depression Scale 
HADS-A = Hospital Anxiety and Depression Scale – anxiety subscale 
HADS-D = Hospital Anxiety and Depression Scale – depression subscale 
HR = Hazard ratio 
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Introduction 
Depressive and anxiety symptoms have consistently been shown to predict poorer 
outcomes in patients with acute coronary syndrome (1, 2). However, randomised trials 
have failed to show any cardiovascular benefit from the treatment of depressive 
symptoms (3). Therefore, more recent studies on depression have begun to critique the 
heterogeneous concept of major depressive disorder, and unpick different symptoms as 
being more ‘cardiotoxic’ than others (4-7). 
 
The most commonly reported finding is that clusters of ‘somatic/affective’ symptoms of 
depression predict prognosis, but that cognitive/affective symptoms do not (4, 5). 
Recently, Carney and Freedland (5) described several limitations with this literature on 
somatic versus cognitive depressive symptoms which need to be addressed. They 
concluded that depression (overall), and not specific symptom subtypes, was the most 
appropriate explanation for elevated rates of morbidity and mortality in persons who 
report depressive symptoms. However, they did not take account of at least three 
studies which suggested that anhedonia may be more important than either somatic or 
cognitive symptoms of depression (6, 8, 9). We first speculated on the importance of 
anhedonia due to one study on persons with ACS which showed that the Hospital 
Anxiety and Depression Scale (Depression subscale; HADS-D), predicted one-year 
mortality, whereas the Beck Depression Inventory – Fast Screen (BDI-FS) did not (8). 
As the HADS-D focusses mainly on anhedonia, we concluded that anhedonia was 
especially important for cardiovascular prognosis. Subsequently, Davidson et al. 
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showed specifically that anhedonic symptoms, either scale-assessed or interviewer-
rated, predicted cardiovascular prognosis, even when controlling for somatic symptoms 
of depression (9).  
 
However, our initial study was underpowered, with a low one-year mortality rate (8). 
Furthermore, the effect sizes for both the BDI-FS and HADS-D scales were not 
significantly different in post-hoc analyses. It is therefore possible that longer-term 
follow-up could demonstrate that both scales predict mortality equivalently. Indeed, this 
would be expected if depression, and not specific depressive symptoms, predict 
prognosis (5). Furthermore, it is unknown whether long-term prognostic ability of the 
HADS-D survives adjustment for symptoms of anxiety. We report eight-year follow-up 
data from a previously published cohort to test these assumptions.  
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Methods 
Participants: 
The methods have been described in detail previously (8). In brief, all centres nationally 
admitting ACS patients recruited patients to a study of treatments for ACS (10). After 
ethical approval, hospitals distributed the HADS (n=19) or the BDI-FS (n=19), as per 
random assignment. Consecutive ACS patients were recruited by hospital staff and 
provided informed consent. Patients then completed either scale during 
hospitalisation, and demographic and clinical data were obtained from hospital charts. 
Mortality outcomes were assessed via a national registry during August 2011. 
 
Measures: 
The HADS is a commonly used 14-item instrument to assess symptoms of anxiety (7-
items) and depression (7-items) in hospitalised samples (11). The BDI-FS is a brief, 7-
item version of the full-length BDI, which assesses sadness, anhedonia and cognitive 
symptoms of depression (12). Both scales attempt to minimise the possible over-
inflation of depression scores by omitting somatic symptoms, and have god sensitivity 
and specificity for identifying major depression when adopting recommended thresholds 
(>7 for HADS-D and HADS-A, >3 for BDI-FS) (13, 14). For each scale, items are scored 
in a 0-3 format, yielding total scale scores of 0-21. 
 
Analyses 
6 
 
As data clustered within hospitals, Huber-White robust variance estimation commands 
were used in Stata version 12.0 to adjust standard errors. The Χ2-test or Student’s t-test 
was used to assess differences between HADS and BDI-FS groups, as appropriate. 
Pearson’s correlation showed the relationship between HADS subscales. Cox 
proportional hazards regression estimated hazard ratios (HRs) for all-cause mortality. 
Scales were analysed as continuous and dichotomous variables, using recommended 
thresholds, and these thresholds were used for drawing Kaplan-Meier curves. 
Demographic and clinical variables were investigated as predictors of mortality, and 
were used for co-variate adjustment. Adjusted model 1 used demographic variables 
along with length of hospital stay as a proxy indicator of disease severity. Model 2 
adjusted for all variables except the following: total cholesterol (too many missing 
values), prior revascularisation, prior myocardial infarction or prior unstable angina 
(these correlated with or are subsets of prior ACS, which was included in the model).  
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Results 
Baseline characteristics are shown in Table 1, stratified by group. The HADS was 
completed by 316 participants, with the BDI-FS being completed by 282. Total 
cholesterol was the only variable which showed a difference between groups. The 
HADS-D and HADS-A were significantly correlated (r=0.55, p<0.001), and previous 
research suggests these formed a single dimension (15).  
------- 
Table 1 about here 
------- 
 
At 8 years, 20.2% (121/598) of participants had died, but there was no difference in 
mortality rate between those who completed the HADS or those who completed the 
BDI-FS (OR=1.05, 95% CI 0.65-1.67, p=0.853). Univariate predictors of mortality are 
shown in Table 1.Of the demographic and clinical variables, only prior myocardial 
infarction or prior revascularisation did not predict outcome. Mortality was not predicted 
by scoring above threshold on either depression scale, or the individual BDI-FS or 
HADS-A scales. Only the HADS-D scale predicted outcome, and this association 
remained when adjusting for the HADS-A (HR=1.17, 95% CI 1.08-1.27, p<0.001). Fig 1 
shows the survival curves. 
 
------- 
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Fig 1 about here 
------- 
 
When adjusting for other co-variates, scoring above threshold on either depression 
scale became significant (Table 2). However, this association was driven by the HADS-
D subscale, as the HADS-D remained a significant predictor of prognosis in both 
multivariate models. These findings were unchanged when scales were analysed 
as dichotomous variables. 
------- 
Table 2 about here 
------- 
 
We conducted item-level analysis to determine which components of the scales were 
predicting outcomes (Table 3). For the HADS-D, anhedonic symptoms, as well as 
feeling slowed, were predictive of mortality. No items from the HADS-A or BDI-FS were 
associated with outcomes. 
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Discussion 
The present study shows that only symptoms of anhedonia and feeling slowed, but not 
other depressive or anxiety symptoms, predict prognosis in persons with ACS. This 
supports previous work in that symptoms of anhedonia were predictive of outcomes, 
and that the HADS-D scale was predictive of outcomes, but the BDI-FS was not (6, 9). It 
also adds to this work as the association between the HADS-D and 8-year mortality 
survived adjustment for HADS-A, despite the high correlation between these scales, 
and the fact that they may be better seen as a single dimension (15, 16). This may 
suggest that, for cardiovascular prognosis, the dimension of distress may be less 
important than particular symptoms within a dimension. Previous theoretical work has 
suggested a tripartite model of distress (17), incorporating a general dimension of 
distress, but also core symptoms representing either depression (anhedonia) or anxiety 
(autonomic arousal). Our findings support this model, in terms of these general and core 
symptoms of distress, but extend it in the cardiovascular sphere in that anhedonia 
appeared to be pertinent for prognosis, but other symptoms of general distress were 
not. While recent findings suggest that anxiety is predictive of cardiovascular prognosis 
(2), it may be that most of the symptoms assessed by the HADS-A are not particularly 
cardiotoxic. 
 
Therefore, in contrast to recent comment (5), the present findings do suggest that 
certain depressive symptoms are more important than others. If depression per se was 
important for prognosis, then the BDI-FS should have predicted at least some levels of 
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increased risk – especially since it has excellent sensitivity and specificity for major 
depression (14). The present study showed no association, and the direction of the 
association was negative for 4 of the six items. However, the fact that the anhedonia 
item from the BDI-FS did not predict outcomes is in contrast to the above conclusions. 
Although this item was not associated with outcomes, its effect size was in the predicted 
direction. One reason for this may be the language used, or the manner in which the 
items are scored. The HADS had higher average scores for its subscales, and this may 
indicate that it is more sensitive to lower threshold levels of symptoms of distress. The 
BDI-FS, however, leads to very skewed data, with the majority scoring zero on the 
anhedonia item.  The BDI-FS item may not therefore be sensitive enough to capture low 
levels of anhedonia, which seems to be prevalent even in those not reporting high levels 
of distress (18), possibly because it is a symptom that patients do not fear reporting (5). 
Future research investigating this item should supplement it with other items assessing 
anhedonia. As outlined by Davidson et al. (9), anhedonia has specifically been 
associated with behavioural (e.g. sleep, appetite) and biological mechanisms (e.g. 
elevated catecholamine levels, disrupted inflammatory processes and circadian 
rhythms) which are purported to explain the association between depression and 
cardiovascular disease.  Importantly, as anhedonia exists in other psychological 
disorders and general distress (18, 19), it is possible that it may explain the association 
with other disorders and cardiovascular prognosis (9). 
 
We cannot rule out the possibility that culture may affect the reported findings (20). It is 
possible that the Irish population may be more responsive to the more colloquial 
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questions of the HADS, and therefore may be more likely to respond to such questions. 
If this is the case, it may be that researchers investigating the association between 
depressive symptoms and prognosis should use scales with predictive validity in their 
own setting.  
 
That the symptom of feeling slowed predicted prognosis, alongside anhedonic 
symptoms, is particularly intriguing. While this item may refer to fatigue, it is also 
possible that it could also be interpreted to mean feeling cognitively slowed. Cognitive 
decline has been associated with cardiovascular disease (21, 22), and further research 
into this possibility is warranted. 
 
The study has a number of limitations. We cannot rule out other factors that may explain 
the association between the HADS-D and prognosis, despite the fact that the hospitals 
were randomised to these scales, and the fact that there was no difference in mortality 
rate between groups. For example, left ventricular function was not recorded, and has 
been shown in some studies to attenuate the depression-outcomes association (23), 
and somatic symptoms of depression were not measured. Furthermore, patients only 
competed one of the scales, however, we have shown similar findings in a one-year 
follow-up of a different sample where patients completed both the HADS-D and BDI-FS 
(6). The use of independent samples also limits the study in that it prevents direct 
comparison of each scale and adjustment for each other, and biases to null findings by 
reducing study power. There is also the possibility that the effect of anhedonia are 
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accounted for by their association with somatic symptoms, which were not assessed in 
the present study. While this was not shown to be the case in another study (9), a 
mixture of dissatisfaction/anhedonia has tended to load on a somatic factor in other 
research (4, 24).  
 
Other constructs, such as fatigue and vital exhaustion, have also been associated 
with cardiovascular prognosis (3, 25, 26). Given the current scientific interest in 
depressive subtypes in cardiac patients (5, 25-28), it is important to critically 
evaluate the overlap between constructs and the factor analytic techniques used 
to differentiate these (3, 5, 6, 26, 29). With reference to the current findings, and 
those by Davidson et al. (9), it appears especially pertinent for future work to 
establish the relationship between anhedonia and fatigue/somatic depressive 
subtypes. Such work may also be of further theoretical value if based on the 
tripartite model of distress (17), incorporating specific measures of anxiety, but 
also a broader range of general distress measures (26). 
 
In conclusion, the HADS-D scale seems to assess symptoms which are important for 
predicting cardiovascular prognosis, despite these symptoms being highly correlated 
with other symptoms of anxiety. Specifically, anhedonia and feeling physically or 
cognitively slowed were especially pertinent for cardiovascular prognosis, but other 
depressive and anxiety symptoms were not. Whether symptoms of distress predict 
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prognosis in ACS may be dependent on the symptoms reported, or on the measures 
and items used. 
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 Table 1: Baseline characteristics of sample (n, % unless otherwise stated), with univariate predictors of 8-year mortality 
 Completed 
HADS 
(n=316) 
Completed 
BDI-FS 
(n=282) 
P-
value 
Hazard 
Ratio 
(HR) 
95% 
Confidence 
Interval (CI) 
P-value 
Demographics       
   Age (years) (mean) (SD) 63 (13) 62 (12) 0.331 1.10 1.08–1.12 <0.001*** 
   Men  235 (74) 221 (78) 0.343 0.50 0.33–0.79 0.003** 
   Health insurance (private)  116 (37) 101 (37) 0.963 0.57 0.37–0.85 0.006** 
Previous risk factor history       
   Prior diabetes  37 (12) 35 (12) 0.826 1.96 1.15–3.33 0.013* 
   Total cholesterol (mmol/l) (mean) (SD)  4.9 (1.2) 5.1 (1.1) 0.014* 0.66 0.57–0.78 <0.001*** 
   Ever smoker  241 (77) 215 (78) 0.949 0.62 0.43–0.90 0.011* 
   Prior ACS  112 (35) 111 (37) 0.440 1.74 1.24–2.46 0.002** 
     Myocardial infarction  60 (19) 59 (20) 0.509 1.37 0.91–2.07 0.133 
     Unstable angina  57 (18) 53 (18) 0.849 2.29 1.50–3.50 <0.001*** 
   Prior revascularisation  47 (15) 56 (19) 0.165 0.81 0.53–1.25 0.342 
   Prior hypertension  132 (41) 115 (41) 0.832 1.79 1.23–2.59 0.002** 
   Reperfusion received  109 (34) 89 (32) 0.533 0.52 0.33–0.80 0.003** 
   Hospital stay (days, median, interquartile range)  9 (5-13) 8 (6-13) 0.159 1.03 1.02–1.05 <0.001*** 
Psychometrics       
   Depressed (above threshold on either scale)    1.45 0.93–2.25 0.101 
   HADS-D (mean, SD) 4.23 (3.26) - - 1.11 1.04–1.19 0.003** 
   HADS-A (mean, SD) 6.83 (4.03) - - 0.96 0.85–1.09 0.564 
   BDI-FS (mean, SD) - 1.95 (2.67) - 0.99 0.91–1.08 0.886 
*p<0.05 
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Table 2: Adjusted predictors of 8-year mortality 
 Model 1   Model 2   
 Hazard 
Ratio 
(HR) 
95% 
Confidence 
Interval (CI) 
p-value Hazard 
Ratio 
(HR) 
95% 
Confidence 
Interval (CI) 
p-
value 
Depressed (above 
threshold on either 
scale) 
1.91 1.16–3.14 0.011* 1.61 1.03–2.53 0.036* 
   HADS-D 
(continuous) (n=302) 
1.11 1.03–1.21 0.007** 1.09 1.00–1.09 0.045* 
   HADS-D 
(dichotomous) 
2.64 1.38–5.05 0.003** 2.47 1.38–4.40 0.002*
* 
   BDI-FS (continuous) 
(n=272) 
1.02 0.88–1.15 0.799 1.01 0.90–1.14 0.834 
   BDI-FS 
(dichotomous) 
1.43 0.68–2.98 0.344 1.24 0.61–2.49 0.553 
Anxiety  
   HADS-A 
(continuous) (n=302)  
1.05 0.95–1.15 0.339 1.03 0.94–1.12 0.558 
   HADS-A 
(dichotomous) 
1.48 0.72–3.02 0.283 1.26 0.63–2.51 0.518 
Model 1 – Adjusted for age, sex, private health insurance, length of hospital stay 
Model 2 - Adjusted for age, sex, private health insurance, diabetes, ever smoker, prior 
ACS, hypertension, reperfusion and length of hospital stay 
*p<0.05  
19 
 
Table 3: Mean score of items, and item-level prediction of 8-year mortality 
 Mean 
score 
HR 95% 
Confidence 
Interval (CI) 
p-value 
HADS-D     
2 – I still enjoy the things I used to enjoy~ 0.63 1.38 1.05–1.82 0.021* 
4 – I can laugh and see the funny side of 
things~ 0.34 1.48 1.11–1.96 0.007** 
6 – I feel cheerful~ 0.47 1.30 0.99–1.72 0.059 
8 – I feel as if I am slowed down 1.39 1.66 1.24–2.22 0.001** 
10 – I have lost interest in my appearance 0.49 0.86 0.62–1.19 0.361 
12 – I look forward with enjoyment to 
things~ 0.54 1.36 1.08–1.72 0.010* 
14 – I can enjoy a good book, radio or TV 
programme~ 0.39 1.08 0.79–1.46 0.645 
HADS-A     
1 – I feel tense or wound up 1.05 0.90 0.61–1.33 0.608 
3 – I get a sort of frightened feeling as if 
something awful is about to happen 1.14 0.99 0.75–1.30 0.934 
5 – Worrying thoughts go through my mind 1.12 1.02 0.82–1.28 0.842 
7 – I can sit at ease and feel relaxed~ 0.78 0.80 0.52–1.21 0.287 
9 – I get a sort of frightened feeling like 
‘butterflies’ in my stomach 0.67 0.96 0.64–1.44 0.842 
11 – I feel restless as if I have to be on the 
move 1.23 0.91 0.67–1.24 0.551 
13 – I get sudden feelings of panic 0.79 1.35 0.95–1.93 0.096 
     
BDI–FS items     
1 – Sadness  0.18 0.69 0.26–1.82 0.451 
2 – Pessimism 0.32 0.80 0.41–1.56 0.512 
3 – Past failure 0.29 0.93 0.57–1.52 0.784 
4 – Loss of pleasure 0.41 1.12 0.73–1.72 0.609 
5 – Self-dislike 0.26 1.14 0.76–1.70 0.539 
6 – Self-criticalness  0.41 0.85 0.60–1.21 0.364 
7 – Suicidality$ 0.06 – – – 
$No patient who indicated suicidality had died at follow–up 
~Items which have negatively-worded responses 
*p<0.05 
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Figure 1: Kaplan–Meier survival curves for depression and anxiety, using recommended 
thresholds 
